Laryngeal manifestations of gastroesophageal reflux disease

Current Gastroenterology Reports

Volumn 10, Issue 3, 2008, Pages 271-277

  Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

BEDTIME DOSAGE; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DIAGNOSTIC TEST; DIET THERAPY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ERYTHEMA; ESOPHAGEAL PH MONITORING; EVENING DOSAGE; GASTROESOPHAGEAL REFLUX; HOARSENESS; HUMAN; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; LARYNX EDEMA; LARYNX MUCOSA; LIFESTYLE MODIFICATION; NONHUMAN; PATHOPHYSIOLOGY; PATIENT EDUCATION; REVIEW; SENSITIVITY AND SPECIFICITY; SORE THROAT; STOMACH FUNDOPLICATION; SYMPTOM; TREATMENT DURATION; ENDOSCOPY; LARYNX DISORDER; PHARYNX DISEASE;

ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGEAL DISEASES; PHARYNGEAL DISEASES; PROTON PUMP INHIBITORS;

EID: 54049085462     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0055-2     Document Type: Review

References (51)

1. Vaezi MF, Hicks DM, Abelson TI, Richter JE: Laryngeal signs and symptoms and gastroesophageal reflux disease: A critical assessment of cause and effect association. Clin Gastroenterol Hepatol 2003, 1:333-344.
2. Ford CN: Evaluation and management of laryngopharyngeal reflux. JAMA 2005, 294:1534-1540.
3. Hicks DM, Ours TM, Abelson TI, et al.: The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002, 16:564-579.
4. Merati AL, Lim HJ, Ulualp SO, Toohill RJ: Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 2005, 114:177-182.
5. Aviv JE, Liu H, Parides M, et al.: Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. Ann Otol Rhinol Laryngol 2000, 109:1000-1006.
6. Hanson DG, Jiang JJ: Diagnosis and management of chronic laryngitis associated with reflux. Am J Med 2000, 108:112S-119S.
7. Johnston N, Bulmer D, Gill GA, et al.: Cell biology of laryngeal epithelial defenses in health and disease: Further studies. Ann Otol Rhinol Laryngol 2003, 112:481-491.
8. Eckley CA, Rios LD, Rizzo LV: Salivary EGF concentration in adults with reflux chronic laryngitis before and after treatment: Preliminary results. Rev Bras Otorrinolaringol (Engl Ed) 2007, 73:156-160.
9. Loughlin CJ, Koufman JA, Averill DB, et al.: Acid-induced laryngospasm in a canine model. Laryngoscope 1996, 106:1506-1509.
10. Adhami T, Goldblum JR, Richter JE, Vaezi MF: The role of gastric and duodenal agents in laryngeal injury: An experimental canine model. Am J Gastroenterol 2004, 99:2098-2106.
11. Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991, 101:1-78.
12. Koufman JA, Amin MR, Panetti M: Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000, 123:385-388.
13. Ahmed TF, Khandwala F, Abelson TI, et al.: Chronic laryngitis associated with gastroesophageal reflux: Prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol 2006, 101:470-478.
14. Book DT, Rhee JS, Toohill RJ, Smith TL: Perspectives in laryngopharyngeal reflux: An international survey. Laryngoscope 2002, 112:1399-1406.
15. Belafsky PC, Postma GN, Koufman JA: Validity and reliability of the reflux symptom index (RSI). J Voice 2002, 16:274-277.
16. Al-Sabbagh G, Wo JM: Supraesophageal manifestations of gastroesophageal reflux disease. Semin Gastrointest Dis 1999, 10:113-119.
17. Milstein CF, Charbel S, Hicks DM, et al.: Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs flexible laryngoscope). Laryngoscope 2005, 115:2256-2261.
18. Vavricka SR, Storck CA, Wildi SM, et al.: Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol 2007, 102:716-722.
19. Vaezi MF: Are there specific laryngeal signs for GERD? Am J Gastroenterol 2007, 102:723-724.
20. Park W, Hicks DM, Khandwala F, et al.: Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005, 115:1230-1238.
21. Branski RC, Bhattacharyya N, Shapiro J: The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002, 112:1019-1024.
22. Swoger J, Ponsky J, Hicks DM, et al.: Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: A controlled study. Clin Gastroenterol Hepatol 2006, 4:433-441.
23. Belafsky PC, Postma GN, Koufman JA: The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001, 111:1313-1317.
24. Kelchner LN, Horne J, Lee L, et al.: Reliability of speech-language pathologist and otolaryngologist ratings of laryngeal signs of reflux in an asymptomatic population using the reflux finding score. J Voice 2007, 21:92-100.
25. Noordzij JP, Khidr A, Desper E, et al.: Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscopy 2002, 112:2192-2195.
26. Jacob P, Kahrilas PJ, Herzon G: Proximal esophageal pH-metry in patients with "reflux laryngitis." Gastroenterology 1991, 100:305-310.
27. Shaker R, Milbrath M, Ren J, et al.: Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995, 109:1575-1582.
28. Eubanks TR, Omelanczuk PE, Maronian N, et al.: Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux. J Gastrointest Surg 2001, 5:183-190.
29. Vaezi MF, Schroeder PL, Richter JE: Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 1997, 92:825-829.
30. Kawamura O, Aslam M, Rittmann T, et al.: Physical and pH properties of gastroesophagopharyngeal refluxate: A 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol 2004, 99:1020-1022.
31. Vaezi MF: Reflux-induced laryngitis (laryngopharyngeal reflux). Curr Treat Options Gastroenterol 2006, 9:69-74.
32. Sifrim D, BlonTeau K: Technology insight: the role of impedance testing for esophageal disorders. Nat Clin Pract Gastroenterol Hepatol 2006, 3:210-219.
33. Mainie I, Tutuian R, Shay S, et al.: Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006, 55:1398-1402.
34. Mainie I, Tutuian R, Agrawal A, et al.: Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006, 93:1483-1487.
35. Shay S, Tutuian R, Sifrim D, et al.: Twenty-four hour ambulatory simultaneous impedance and pH monitoring: A multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004, 99:1037-1043.
36. Vaezi MF, Hicks DM, OArs TM, Richter JE: ENT manifestation of GERD: a large prospective study assessing treatment outcome and predictors of response. Gastroenterology 2001, 120:A636.
37. Steward DL, Wilson KM, Kelly DH, et al.: Proton pump inhibitor therapy for chronic laryngo-pharyngitis: A randomized placebo-control trial. Otolaryngol Head Neck Surg 2004, 131:342-350.
38. Vaezi MF: Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone 2003, 5:32-38.
39. El-Serag HB, Lee P, Buchner A, et al.: Lansoprazole treatment of patients with chronic idiopathic laryngitis: A placebo-controlled trial. Am J Gastroenterol 2001, 96:979-983.
40. Havas T, Huang S, Levy MD et al.: Posterior pharyngolaryngitis: double blind randomized placebo controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 1999, 3:243-246.
41. Vaezi MF, Richter JE, Stasney CR, et al.: Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006, 116:254-260.
42. Wo JM, Koopman J, Harrell SP, et al.: Double blind, placebo controlled trial with single dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 2006, 101:1972-1978.
43. Qadeer MA, Phillips CO, Lopez AR, et al.: Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: A meta-analysis of randomized controlled trials. Am J Gastroenterol 2006, 101:2646-2654.
44. Kamel PL, Hanson D, Kahrilas PJ: Omeprazole for the treatment of posterior laryngitis. Am J Med 1994, 96:321-326.
45. Wo JM, Grist WJ, Gussack G, et al.: Empiric trial of high-dose omeprazole in patients with posterior laryngitis: A prospective study. Am J Gastroenterol 1997, 92:2160-2165.
46. Peghini PL, Katz PO, Bracy NA, Castell DO: Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998, 93:763-767.
47. Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects. Gastroenterology 1998, 115:1335-1339.
48. Fackler WK, Ours TM, Vaezi MF, Richter JE: Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 2002, 122:625-632.
49. Ours TM, Fackler WK, Richter JE, Vaezi MF: Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 2003, 98:545-550.
50. Vaezi MF, Lopez R, Hicks D, et al.: What is the optimal initial therapy duration for patients with suspected GERD-related laryngitis? Gastroenterology 2005, 128:M1769.
51. Eherer AJ, Habermann W, Hammer HF, et al.: Effect of pantoprazole on the course of reflux-associated laryngitis: A placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003, 38:462-467.